Clinical Trials Browser

Completed × Neoplastic Cells, Circulating × Trastuzumab × Clear all

NCT01548677 2019-03-13

TREAT-CTC

Phase 2 Completed

Breast Neoplasms, Neoplastic Cells, Circulating